Search

everythinglearnresearchcommunity

for

Search:↓

No significant link between male pattern baldness and COVID-19 severity was found.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

People undergoing chemotherapy need better support and information to cope with hair loss.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Microneedling is a safe and effective treatment for various skin conditions, often preferred for its fewer side effects and shorter recovery time.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.